Abcam, ab252725, Anti-Norovirus GII.4 antibody [B1934M]

Size: 250µg
Mouse Monoclonal Norovirus GII.4 antibody. Carrier free. Suitable for ELISA and reacts with Norovirus samples. Cited in 1 publication. Immunogen corresponding to Virus preparation containing Norovirus GII.4 protein.
Key facts
Host species:Mouse,
Clonality:Monoclonal,
Clone number:B1934M,
Isotype:IgG1,
Carrier free:Yes,
Reacts with:Norovirus,
Applications:ELISASee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.,
Specificity:Recognizes Norovirus virus-like particle (VLP) from GII.4 2002-2010.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Purification notes-Purified from tissue culture supernatant., Storage buffer-Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Norovirus GII.4 also known as norwalk-like virus or Norwalk virus GII.4 is a strain of human norovirus. Norovirus is a small non-enveloped virus with a 38-40 kDa capsid protein known as VP1 which forms its protective coat. GII.4 genotype is particularly known for its role in human gastroenteritis outbreaks. Researchers often find it expressed in the gastrointestinal tract where it initiates infection. The VP1 protein plays a central mechanical role in norovirus binding and entry into host cells through interaction with histo-blood group antigens (HBGAs).
Biological function summary
Norovirus GII.4 impacts host cells by hijacking cellular machinery to replicate and spread. It is not part of a larger protein complex but instead is a self-sufficient entity that coordinates replication discreetly. The virus often triggers an immune response characterized by the activity of innate immune molecules such as interferons. It primarily disrupts the normal function of intestinal cells leading to symptomatic gastroenteritis.
Pathways
Virus replication starts in the host's environment facilitated by internal processes such as autophagy and the unfolded protein response. Norovirus GII.4 participates in the viral replication pathway interacting with host proteins particularly those involved in the immune response. Molecular players like RIG-I an immune sensor engage with norovirus RNA genomes leading to the activation of downstream signaling cascades important for antiviral defense.
Norovirus GII.4 is a leading cause of sporadic gastroenteritis and major outbreaks of acute diarrhea worldwide. The virus can spread quickly particularly in densely populated environments like cruise ships and nursing homes. In severe cases co-infections may involve other pathogens like rotavirus complicating the clinical outcomes. The understanding of how Norovirus GII.4 and similar enteric viruses cause disease aids in developing vaccines and therapeutic strategies to control its impact on public health.